The intravenous maintenance dose. This mode has been described Zuspan. Load dose of 5 g w / w (or in some cases, 5 g w / w), introduced in the same manner as described above, followed by a long w / w introduction of the drug at the rate of 1 gram per hour for 24 hours. In most cases, speed Infusion controlled manually. Repeated convulsions. Using both regimes occur if repeated episodes of apnoea, in addition to / for a period of 5 minutes imposed from 2 to 4 grams of the drug for more (depending on the weight of the patient, if it was less than 70 kg, were injected 2 g). Monitoring during treatment magnesium sulphate Magnesium sulphate not have a sedative action, and after convulsing woman must be in the minds. However, magnesium can oppress nervno- muscle transfer in neurotransmission, which can lead to paralysis if the concentration of magnesium in serum will be enhanced. A rational for the clinical research is the study of knee reflex and his disappearance may be expected oppression, or even stop breathing. Thus, frequent monitoring knee reflex and the patient needed to minimize the risk of complications in the use of magnesium sulfate. You may also need to bear in mind that magnesium display kidneys, which is why kidney failure magnesium intake should be reduced. Monitoring using magnesium sulfate in this study was based on clinical and assurance of the absence of oppression breathing, a knee reflex and adequately functioning kidneys. Monitoring the concentration of magnesium in serum has been made.